Details |
MD |
1 |
3SN6 |
Beta-2 adrenergic receptor (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.2 |
Nature |
2011 |
Details |
MD |
2 |
4ZWJ |
Rhodopsin (R) |
Rhodopsin-like / A |
Homo sapiens |
Arrestin (A) |
|
3.3 |
Nature |
2015 |
Details |
MD |
3 |
5DGY |
Rhodopsin (R) |
Rhodopsin-like / A |
Homo sapiens |
Arrestin (A) |
|
7.7 |
Sci Data |
2016 |
Details |
MD |
4 |
5G53 |
Adenosine receptor A2a (A) |
Rhodopsin-like / A |
Homo sapiens |
G: α (C) |
|
3.4 |
Nature |
2016 |
Details |
MD |
5 |
5UZ7 |
Calcitonin receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
|
4.1 |
Nature |
2017 |
Details |
MD |
6 |
5VAI |
Glucagon like peptide 1 receptor (R) |
Secretin / B1 |
Oryctolagus cuniculus |
G: α β γ (A B G) |
Glucagon-like peptide 1 (P) |
4.1 |
Nature |
2017 |
Details |
MD |
7 |
5W0P |
Rhodopsin (R) |
Rhodopsin-like / A |
Homo sapiens |
Arrestin (A) |
|
3.0 |
Cell |
2017 |
Details |
MD |
8 |
6B3J |
Glucagon-like peptide 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Exendin-P5 (P) |
3.3 |
Nature |
2018 |
Details |
MD |
9 |
6CMO |
Rhodopsin (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
4.5 |
Nature |
2018 |
Details |
MD |
10 |
6D9H |
Adenosine receptor A1 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.6 |
Nature |
2018 |
Details |
MD |
11 |
6DDE |
Mu-type opioid receptor (R) |
Rhodopsin-like / A |
Mus musculus |
G: α β γ (A B C) |
DAMGO (D) |
3.5 |
Nature |
2018 |
Details |
MD |
12 |
6DDF |
Mu-type opioid receptor (R) |
Rhodopsin-like / A |
Mus musculus |
G: α β γ (A B C) |
DAMGO (D) |
3.5 |
Nature |
2018 |
Details |
MD |
13 |
6E3Y |
Calcitonin gene-related peptide type 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Calcitonin gene-related peptide 1 (P), Receptor activity-modifying protein 1 (E) |
3.3 |
Nature |
2018 |
Details |
MD |
14 |
6FUF |
Rhodopsin (A) |
Rhodopsin-like / A |
Bos taurus |
G: α (B) |
|
3.1 |
Sci Adv |
2018 |
Details |
MD |
15 |
6G79 |
5-hydroxytryptamine receptor 1B (S) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.8 |
Nature |
2018 |
Details |
MD |
16 |
6GDG |
Adenosine receptor A2a (A) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (D B C) |
|
4.1 |
Elife |
2018 |
Details |
MD |
17 |
6K41 |
Alpha-2B adrenergic receptor (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
2.9 |
Nat Chem Biol |
2020 |
Details |
MD |
18 |
6K42 |
Alpha-2B adrenergic receptor (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
4.1 |
Nat Chem Biol |
2020 |
Details |
MD |
19 |
6KPF |
Cannabinoid receptor 2 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
|
2.9 |
Cell |
2020 |
Details |
MD |
20 |
6KPG |
Cannabinoid receptor 1 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
|
3.0 |
Cell |
2020 |
Details |
MD |
21 |
6LFM |
C-X-C chemokine receptor type 2 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
Interleukin-8 (D,E) |
3.5 |
Nature |
2020 |
Details |
MD |
22 |
6LFO |
C-X-C chemokine receptor type 2 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
Interleukin-8 (D) |
3.4 |
Nature |
2020 |
Details |
MD |
23 |
6LI3 |
G-protein coupled receptor 52 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.3 |
Nature |
2020 |
Details |
MD |
24 |
6LMK |
Glucagon receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B C) |
Glucagon (E) |
3.7 |
Science |
2020 |
Details |
MD |
25 |
6LML |
Glucagon receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B C) |
Glucagon (E) |
3.9 |
Science |
2020 |
Details |
MD |
26 |
6LPB |
Pituitary adenylate cyclase-activating polypeptide type I receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Pituitary adenylate cyclase-activating polypeptide (P) |
3.9 |
Nat Struct Mol Biol |
2020 |
Details |
MD |
27 |
6M1H |
Pituitary adenylate cyclase-activating polypeptide type I receptor (A) |
Secretin / B1 |
Homo sapiens |
G: α β γ (F E D) |
Maxadilan (B) |
3.6 |
Cell Res |
2020 |
Details |
MD |
28 |
6M1I |
Pituitary adenylate cyclase-activating polypeptide type I receptor (A) |
Secretin / B1 |
Homo sapiens |
G: α β γ (F E D) |
Pituitary adenylate cyclase-activating polypeptide (B) |
3.5 |
Cell Res |
2020 |
Details |
MD |
29 |
6N4B |
Cannabinoid receptor 1 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
|
3.0 |
Cell |
2019 |
Details |
MD |
30 |
6NBF |
Parathyroid hormone/parathyroid hormone-related peptide receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Long-acting parathyroid hormone analog (P) |
3.0 |
Science |
2019 |
Details |
MD |
31 |
6NBH |
Parathyroid hormone/parathyroid hormone-related peptide receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Long-acting parathyroid hormone analog (P) |
3.5 |
Science |
2019 |
Details |
MD |
32 |
6NBI |
Parathyroid hormone/parathyroid hormone-related peptide receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Long-acting parathyroid hormone analog (P) |
4.0 |
Science |
2019 |
Details |
MD |
33 |
6NI3 |
Beta-2 adrenergic receptor (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.8 |
Nat Struct Mol Biol |
2019 |
Details |
MD |
34 |
6NIY |
Calcitonin receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Calcitonin (P) |
3.3 |
ACS Pharmacol Transl Sci |
2019 |
Details |
MD |
35 |
6OIJ |
Muscarinic acetylcholine receptor M1 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.3 |
Science |
2019 |
Details |
MD |
36 |
6OIK |
Muscarinic acetylcholine receptor M2 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.6 |
Science |
2019 |
Details |
MD |
37 |
6OMM |
N-formyl peptide receptor 2 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
Peptide agonist (L) |
3.2 |
Nat Commun |
2020 |
Details |
MD |
38 |
6ORV |
Glucagon-like peptide 1 receptor (E) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
|
3.0 |
Nature |
2020 |
Details |
MD |
39 |
6OS9 |
Neurotensin receptor type 1 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
JMV449 (L) |
3.0 |
Nature |
2019 |
Details |
MD |
40 |
6OSA |
Neurotensin receptor type 1 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
JMV449 (L) |
3.0 |
Nature |
2019 |
Details |
MD |
41 |
6OT0 |
Smoothened homolog (R) |
Frizzled / F |
Homo sapiens |
G: α β γ (A B G) |
|
3.8 |
Nature |
2019 |
Details |
MD |
42 |
6OY9 |
Rhodopsin (R) |
Rhodopsin-like / A |
Bos taurus |
G: α β γ (A B G) |
|
3.9 |
Mol Cell |
2019 |
Details |
MD |
43 |
6OYA |
Rhodopsin (R) |
Rhodopsin-like / A |
Bos taurus |
G: α β γ (A B G) |
|
3.3 |
Mol Cell |
2019 |
Details |
MD |
44 |
6P9X |
Corticotropin-releasing factor receptor 1 (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Corticoliberin (P) |
2.9 |
Mol Cell |
2020 |
Details |
MD |
45 |
6P9Y |
Pituitary adenylate cyclase-activating polypeptide type I receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Pituitary adenylate cyclase-activating polypeptide (P) |
3.0 |
Mol Cell |
2020 |
Details |
MD |
46 |
6PB0 |
Corticotropin-releasing factor receptor 1 (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Urocortin (U) |
3.0 |
Mol Cell |
2020 |
Details |
MD |
47 |
6PB1 |
Corticotropin-releasing factor receptor 2 (P) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Urocortin (U) |
2.8 |
Mol Cell |
2020 |
Details |
MD |
48 |
6PT0 |
Cannabinoid receptor 2 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
|
3.2 |
Cell |
2020 |
Details |
MD |
49 |
6PWC |
Neurotensin receptor type 1 (R) |
Rhodopsin-like / A |
Homo sapiens |
Arrestin (A) |
Neurotensin peptide (B) |
4.9 |
Cell Res |
2019 |
Details |
MD |
50 |
6QNO |
Rhodopsin (R) |
Rhodopsin-like / A |
Bos taurus |
G: α β γ (A B G) |
|
4.4 |
Elife |
2019 |
Details |
MD |
51 |
6TKO |
Beta-1 adrenergic receptor (A) |
Rhodopsin-like / A |
Meleagris gallopavo |
Arrestin (B) |
|
3.3 |
Nature |
2020 |
Details |
MD |
52 |
6U1N |
Vasopressin V2 receptor (R) |
Rhodopsin-like / A |
Homo sapiens |
Arrestin (C) |
|
4.0 |
Nature |
2020 |
Details |
MD |
53 |
6UP7 |
Neurotensin receptor type 1 (R) |
Rhodopsin-like / A |
Homo sapiens |
Arrestin (B) |
ARG-ARG-PRO-TYR-ILE-LEU (C) |
4.2 |
Nature |
2020 |
Details |
MD |
54 |
6UUN |
Calcitonin gene-related peptide type 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Adrenomedullin peptide (P), Receptor activity-modifying protein 2 (E) |
3.0 |
ACS Pharmacol Transl Sci |
2020 |
Details |
MD |
55 |
6UUS |
Calcitonin gene-related peptide type 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Adrenomedullin peptide (P), Receptor activity-modifying protein 3 (E) |
2.4 |
ACS Pharmacol Transl Sci |
2020 |
Details |
MD |
56 |
6UVA |
Calcitonin gene-related peptide type 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Adrenomedullin peptide (P), Receptor activity-modifying protein 3 (E) |
2.3 |
ACS Pharmacol Transl Sci |
2020 |
Details |
MD |
57 |
6VCB |
Glucagon-like peptide 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Glucagon-like peptide 1 (P) |
3.3 |
Nat Chem Biol |
2020 |
Details |
MD |
58 |
6VMS |
D(2) dopamine receptor (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B C) |
|
3.8 |
Nature |
2020 |
Details |
MD |
59 |
6WHA |
5-hydroxytryptamine receptor 2A (A) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (B C D) |
|
3.4 |
Cell |
2020 |
Details |
MD |
60 |
6WHC |
Glucagon receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B C) |
Dual-agonist peptide 15 (E) |
3.4 |
J Biol Chem |
2020 |
Details |
MD |
61 |
6WI9 |
Secretin receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Secretin (P) |
4.3 |
Nat Commun |
2020 |
Details |
MD |
62 |
6WPW |
Glucagon receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (C D G) |
Glucagon derivative ZP3780 (P) |
3.1 |
Science |
2020 |
Details |
MD |
63 |
6WWZ |
C-C chemokine receptor type 6 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B Y) |
C-C motif chemokine 20 (C) |
3.3 |
Nat Commun |
2020 |
Details |
MD |
64 |
6WZG |
Secretin receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Secretin (P) |
2.3 |
Nat Commun |
2020 |
Details |
MD |
65 |
6X18 |
Glucagon-like peptide 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Glucagon (P) |
2.1 |
Mol Cell |
2020 |
Details |
MD |
66 |
6X19 |
Glucagon-like peptide 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
|
2.1 |
Mol Cell |
2020 |
Details |
MD |
67 |
6X1A |
Glucagon-like peptide 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
|
2.5 |
Mol Cell |
2020 |
Details |
MD |
68 |
6XBJ |
Smoothened homolog (R) |
Frizzled / F |
Homo sapiens |
G: α β γ (A B G) |
|
3.9 |
Nat Chem Biol |
2020 |
Details |
MD |
69 |
6XBK |
Smoothened homolog (R) |
Frizzled / F |
Homo sapiens |
G: α β γ (A B G) |
|
3.2 |
Nat Chem Biol |
2020 |
Details |
MD |
70 |
6XBL |
Smoothened homolog (R) |
Frizzled / F |
Homo sapiens |
G: α β γ (A B G) |
|
4.0 |
Nat Chem Biol |
2020 |
Details |
MD |
71 |
6XBM |
Smoothened homolog (R) |
Frizzled / F |
Homo sapiens |
G: α β γ (A B G) |
|
3.1 |
Nat Chem Biol |
2020 |
Details |
MD |
72 |
7AD3 |
Pheromone alpha factor receptor (A,B) |
Pheromone / D |
Saccharomyces cerevisiae |
G: α β γ (E,H F G) |
Alpha-factor mating pheromone (I,K) |
3.5 |
Nature |
2021 |
Details |
MD |
73 |
7AD3m |
Pheromone alpha factor receptor (A,B) |
Pheromone / D |
Saccharomyces cerevisiae |
G: α β γ (E,H F,L G,J) |
Alpha-factor mating pheromone (I,K) |
3.5 |
Nature |
2021 |
Details |
MD |
74 |
7BW0 |
Bile acids receptor TGR5 in complex with stimulatory G protein (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.9 |
Signal Transduct Target Ther |
2020 |
Details |
MD |
75 |
7C2E |
Glucagon-like peptide 1 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
|
4.2 |
Cell Res |
2020 |
Details |
MD |
76 |
7CFM |
G-protein coupled bile acid receptor 1 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.0 |
Nature |
2020 |
Details |
MD |
77 |
7CFN |
G-protein coupled bile acid receptor 1 (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.0 |
Nature |
2020 |
Details |
MD |
78 |
7CZ5 |
Growth hormone-releasing hormone receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Somatoliberin (P) |
2.6 |
Nat Commun |
2020 |
Details |
MD |
79 |
7D3S |
Secretin receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Secretin (P) |
2.9 |
Biochem.Biophys.Res.Commun. |
2020 |
Details |
MD |
80 |
7D68 |
Glucagon-like peptide 2 receptor (R) |
Secretin / B1 |
Homo sapiens |
G: α β γ (A B G) |
Pro-glucagon (P) |
3.0 |
Cell Res. |
2020 |
Details |
MD |
81 |
7D7M |
Prostaglandin E2 receptor EP4 subtype (A) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (D B C) |
|
3.3 |
Structure |
2020 |
Details |
MD |
82 |
7DHI |
Beta-2 adrenergic receptor (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.3 |
Natl Sci Rev |
2020 |
Details |
MD |
83 |
7DHR |
Beta-2 adrenergic receptor (R) |
Rhodopsin-like / A |
Homo sapiens |
G: α β γ (A B G) |
|
3.8 |
Natl Sci Rev |
2020 |
Details |
MD |
84 |
7JJO |
Beta-1 adrenergic receptor (R) |
Rhodopsin-like / A |
Meleagris gallopavo |
G: α β γ (A B G) |
|
2.6 |
Mol.Cell |
2020 |